McGuire Investment Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.9M | Sell |
27,805
-335
| -1% | -$161K | 1.22% | 24 |
|
|
2026
Q1 | $13.8M | Sell |
28,140
-5,199
| -16% | -$2.82M | 1.56% | 20 |
|
|
2025
Q4 | $19.3M | Buy |
33,339
+38
| +0.1% | +$21.5K | 2.06% | 16 |
|
|
2025
Q3 | $16.2M | Sell |
33,301
-378
| -1% | -$176K | 1.83% | 17 |
|
|
2025
Q2 | $13.7M | Buy |
33,679
+502
| +2% | +$210K | 1.75% | 16 |
|
|
2025
Q1 | $16.5M | Buy |
33,177
+745
| +2% | +$403K | 2.45% | 15 |
|
|
2024
Q4 | $16.9M | Buy |
32,432
+79
| +0.2% | +$43.4K | 2.44% | 14 |
|
|
2024
Q3 | $20M | Buy |
32,353
+556
| +2% | +$329K | 2.82% | 11 |
|
|
2024
Q2 | $17.6M | Buy |
31,797
+73
| +0.2% | +$41.8K | 2.52% | 14 |
|
|
2024
Q1 | $18.4M | Sell |
31,724
-30
| -0.1% | -$16.8K | 2.69% | 10 |
|
|
2023
Q4 | $16.9M | Buy |
31,754
+674
| +2% | +$326K | 2.81% | 12 |
|
|
2023
Q3 | $15.7M | Buy |
31,080
+725
| +2% | +$386K | 3.03% | 9 |
|
|
2023
Q2 | $15.8M | Sell |
30,355
-610
| -2% | -$329K | 2.95% | 12 |
|
|
2023
Q1 | $17.8M | Sell |
30,965
-1,541
| -5% | -$869K | 3.55% | 6 |
|
|
2022
Q4 | $17.9M | Buy |
32,506
+6
| +0% | +$3.18K | 3.87% | 2 |
|
|
2022
Q3 | $16.5M | Buy |
32,500
+190
| +0.6% | +$106K | 3.76% | 3 |
|
|
2022
Q2 | $17.6M | Sell |
32,310
-214
| -0.7% | -$118K | 3.78% | 4 |
|
|
2022
Q1 | $19.2M | Buy |
32,524
+128
| +0.4% | +$73.5K | 3.52% | 7 |
|
|
2021
Q4 | $21.6M | Sell |
32,396
-65
| -0.2% | -$40.6K | 3.56% | 7 |
|
|
2021
Q3 | $18.5M | Buy |
32,461
+310
| +1% | +$170K | 3.49% | 8 |
|
|
2021
Q2 | $16.2M | Sell |
32,151
-333
| -1% | -$157K | 3.08% | 8 |
|
|
2021
Q1 | $14.8M | Buy |
32,484
+2,401
| +8% | +$1.15M | 3.13% | 8 |
|
|
2020
Q4 | $14M | Buy |
30,083
+29
| +0.1% | +$13.6K | 3.47% | 7 |
|
|
2020
Q3 | $13.3M | Buy |
30,054
+77
| +0.3% | +$31.8K | 3.95% | 4 |
|
|
2020
Q2 | $10.9M | Sell |
29,977
-2,529
| -8% | -$848K | 3.77% | 7 |
|
|
2020
Q1 | $9.22M | Buy |
32,506
+5
| +0% | +$1.58K | 3.84% | 7 |
|
|
2019
Q4 | $10.6M | Buy |
32,501
+436
| +1% | +$132K | 3.14% | 11 |
|
|
2019
Q3 | $9.34M | Buy |
32,065
+197
| +0.6% | +$56.4K | 3.06% | 9 |
|
|
2019
Q2 | $9.36M | Buy |
31,868
+277
| +0.9% | +$76.3K | 2.97% | 10 |
|
|
2019
Q1 | $8.65M | Buy |
31,591
+13
| +0% | +$3.23K | 2.83% | 10 |
|
|
2018
Q4 | $7.07M | Buy |
31,578
+269
| +0.9% | +$63.1K | 2.67% | 12 |
|
|
2018
Q3 | $7.64M | Buy |
+31,309
| New | +$7.2M | 2.53% | 13 |
|
Other funds holding TMO
McGuire Investment Group's TMO Position: Q2 2026 in Review
McGuire Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $161K and leaving 27,805 shares worth $13.9M. The position accounts for 1.22% of the portfolio, ranked #24.
McGuire Investment Group first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $21.6M in Q4 2021. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- McGuire Investment Group held 27,805 shares of Thermo Fisher Scientific worth $13.9M as of Q2 2026.
- McGuire Investment Group sold 335 Thermo Fisher Scientific shares in Q2 2026, an estimated $161K.
- Thermo Fisher Scientific made up 1.22% of McGuire Investment Group's portfolio in Q2 2026, its #24 holding.
- McGuire Investment Group first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- McGuire Investment Group's Thermo Fisher Scientific position peaked at $21.6M in Q4 2021.
- 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.